| According to the company, with CVpill, Torrent Pharma has become the first company to actually launch a polypill. A company release claims that CVpill is the world's first polypill in cardiac care. |
| Ruchir Modi, Head, Strategic Marketing, says, with CVpill, the company has created a completely new segment in cardiology care and aims to clock over Rs 10 crore in sales in the first year of its launch. |
| A patients with multiple cardiovascular risk factors have to take 4-5 medications everyday. The treatment is expensive and there is always the risk of the patient forgetting to take a medicine. The CVpill lets patients experience the simplicity of an 'all-in-one' medication at a cost-effective price. |
| CVpill is available in a kit containing a capsule and a tablet. The capsule contains a statin (Atorvastatin 10 mg), an ACE inhibitor (Ramipril 5 mg) and an anti-platelet agent (Enteric-coated Aspirin 75 mg). |
| The tablet contains a beta blocker (Metoprolol Succinate extended release 50 mg). The CVpill is an innovative combination of these four most recommended molecules used in the treatment for multiple cardiovascular (CV) risk factors. |
| All the four constituents of this kit are standalone molecules with a huge prescription volume and a combined market worth Rs 500 crore. |
Explore Business Standard